Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126355 · ClinicalTrials.gov registry record · NA
Effectiveness of the On the Move Group Exercise Program to Improve Mobility in Community-dwelling Older Adults
A NA study of Mobility Limitation, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 529
- Enrollment target
- 1
- Study location
NCT05126355: Active NA study of Mobility Limitation, sponsored by University of Pittsburgh.
NCT05126355 is a NA study of Mobility Limitation that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 529 participants, above the 237-participant average among 28 other Mobility Limitation trials with a reported enrollment target (123% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05126355, a NA study of Mobility Limitation, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 529 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of On the Move (OTM) in terms of improving mobility among 502 older adults in 44 senior community centers and to evaluate intervention fidelity, including adherence and competence, and the impact of organizational, instructor, and participant level factors on intervention fidelity.
Primary Outcome
The time it take the subject to walk 4 meters and their usual walking speed. Recorded as m/s. Faster speeds indicate better mobility.
Conditions Studied
Interventions
- BEHAVIORAL On the Move group exercise
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 529 participants |
| Start Date | 2022-06-23 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT05126355 still lists
NCT05126355 is an interventional study that assigns participants to a tested intervention. The registered 529 participants enrollment target is mid-sized for trials with a published cap, above the 237-participant average among 28 other Mobility Limitation trials with a reported enrollment target (123% higher).
The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 1 intervention - of which On the Move group exercise is the first listed.
NCT05126355 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05126355 about?
NCT05126355 is a clinical study titled "Effectiveness of the On the Move Group Exercise Program to Improve Mobility in Community-dwelling Older Adults". The purpose of this study is to test the effectiveness of On the Move (OTM) in terms of improving mobility among 502 older adults in 44 senior community centers and to evaluate intervention fidelity, including adherence and competence, and the impact of organizational, instructor, and participant le...
What is the current status of trial NCT05126355?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 529 participants. The study started on 2022-06-23. Estimated completion is 2026-08-31.
What conditions does trial NCT05126355 study?
This clinical trial studies the following conditions: Mobility Limitation.
What interventions are being tested in trial NCT05126355?
The interventions under investigation include: On the Move group exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05126355?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05126355 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mobility Limitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05126355's enrollment target sits among peer trials
529 3rd of 28 higher than 26 of 28 other Mobility Limitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV
ACTIVE NOT RECRUITING · NA
-
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
ACTIVE NOT RECRUITING · NA
-
Randomized Clinical Trial to Improve Mobility After Hospitalization
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- NCT06703476 · 530 participants · Phase 3
A Study of Surgical Techniques During Cystectomy
- NCT06880744 · 530 participants · Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- NCT07138040 · 530 participants · NA
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI